Skip to main content
Veterinary Medicines

EFFIPRO DUO 100 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE CATS

Authorised
This information is not available for this product.

Product identification

Medicine name:
EFFIPRO DUO 100 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE CATS
Effipro duo 100 mg/120 mg solução para unção punctiforme para gatos muito grandes
Active substance:
This information is not available for this product.
Target species:
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Box containing 1 pipette
  • Box containing 4 pipettes
  • Box containing 24 pipettes
  • Box containing 60 pipettes

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 940/06/15DFVPT
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0402/006
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."